These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21160865)

  • 1. Treatment of colorectal carcinoids: A new paradigm.
    Konishi T; Watanabe T; Nagawa H; Oya M; Ueno M; Kuroyanagi H; Fujimoto Y; Akiyoshi T; Yamaguchi T; Muto T
    World J Gastrointest Surg; 2010 May; 2(5):153-6. PubMed ID: 21160865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of treatment for rectal neuroendocrine tumors sized under 20 mm in comparison with the WHO 2010 guidelines.
    Matsuhashi N; Takahashi T; Tomita H; Araki H; Ibuka T; Tanaka K; Tanahashi T; Matsui S; Sasaki Y; Tanaka Y; Okumura N; Yamaguchi K; Osada S; Yoshida K
    Mol Clin Oncol; 2017 Sep; 7(3):476-480. PubMed ID: 28894583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Retrospective investigation of patients receiving additional surgery after endoscopic non-curative resection for early colorectal cancer].
    Sun YM; Zhang DS; Feng YF; Wang Y; Xu ZW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):486-491. PubMed ID: 32842429
    [No Abstract]   [Full Text] [Related]  

  • 4. Lymph-node metastases in rectal carcinoids.
    Fujimoto Y; Oya M; Kuroyanagi H; Ueno M; Akiyoshi T; Yamaguchi T; Muto T
    Langenbecks Arch Surg; 2010 Feb; 395(2):139-42. PubMed ID: 19048280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis and risk factors of metastasis in colorectal carcinoids: results of a nationwide registry over 15 years.
    Konishi T; Watanabe T; Kishimoto J; Kotake K; Muto T; Nagawa H;
    Gut; 2007 Jun; 56(6):863-8. PubMed ID: 17213340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Endoscopic Submucosal Dissection for Colorectal Carcinoids.
    Chen T; Yao LQ; Xu MD; Zhang YQ; Chen WF; Shi Q; Cai SL; Chen YY; Xie YH; Ji Y; Chen SY; Zhou PH; Zhong YS
    Clin Gastroenterol Hepatol; 2016 Apr; 14(4):575-81. PubMed ID: 26256463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AGA Institute Clinical Practice Update: Endoscopic Submucosal Dissection in the United States.
    Draganov PV; Wang AY; Othman MO; Fukami N
    Clin Gastroenterol Hepatol; 2019 Jan; 17(1):16-25.e1. PubMed ID: 30077787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Budding as a risk factor for lymph node metastasis in pT1 or pT2 well-differentiated colorectal adenocarcinoma.
    Okuyama T; Oya M; Ishikawa H
    Dis Colon Rectum; 2002 May; 45(5):628-34. PubMed ID: 12004212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of lymph node metastases from early gastric cancer in relation to depth of invasion: experience in a single institution.
    Wang Z; Ma L; Zhang XM; Zhou ZX
    Asian Pac J Cancer Prev; 2014; 15(13):5371-5. PubMed ID: 25041004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological characteristics of rectal carcinoids.
    Yoon SN; Yu CS; Shin US; Kim CW; Lim SB; Kim JC
    Int J Colorectal Dis; 2010 Sep; 25(9):1087-92. PubMed ID: 20397020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resection with en bloc removal of regional lymph node after endoscopic resection for T1 colorectal cancer.
    Kobayashi H; Higuchi T; Uetake H; Iida S; Ishikawa T; Ishiguro M; Sugihara K
    Ann Surg Oncol; 2012 Dec; 19(13):4161-7. PubMed ID: 22772868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor size and depth predict rate of lymph node metastasis and utilization of lymph node sampling in surgically managed gastric carcinoids.
    Saund MS; Al Natour RH; Sharma AM; Huang Q; Boosalis VA; Gold JS
    Ann Surg Oncol; 2011 Oct; 18(10):2826-32. PubMed ID: 21455598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors of lymph node metastasis in patients with gastric neuroendocrine tumor with normal serum gastrin level.
    Jung JH; Choi KD; Koh YW; Park YS; Jung HY; Lee GH; Song HJ; Kim DH; Choi KS; Lee JH; Ahn JY; Kim MY; Bae SE; Kim JH
    Hepatogastroenterology; 2015; 62(137):207-13. PubMed ID: 25993755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment strategy and post-treatment management of colorectal neuroendocrine tumor.
    Sekiguchi M; Matsuda T; Saito Y
    DEN Open; 2024 Apr; 4(1):e254. PubMed ID: 37313123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological characteristics of rectal carcinoid patients undergoing surgical resection.
    Yamagishi D; Matsubara N; Noda M; Yamano T; Tsukamoto K; Kuno T; Hamanaka M; Kobayashi M; Ikeuchi H; Matsuda I; Hirota S; Tomita N
    Oncol Lett; 2012 Nov; 4(5):910-914. PubMed ID: 23162621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of metastasis and survival of 788 patients with T1 rectal carcinoid tumors.
    Ngamruengphong S; Kamal A; Akshintala V; Hajiyeva G; Hanada Y; Chen YI; Sanaei O; Fluxa D; Haito Chavez Y; Kumbhari V; Singh VK; Lennon AM; Canto MI; Khashab MA
    Gastrointest Endosc; 2019 Mar; 89(3):602-606. PubMed ID: 30447216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment strategy for rectal carcinoids: a clinicopathological analysis of 229 cases at a single cancer institution.
    Kasuga A; Chino A; Uragami N; Kishihara T; Igarashi M; Fujita R; Yamamoto N; Ueno M; Oya M; Muto T
    J Gastroenterol Hepatol; 2012 Dec; 27(12):1801-7. PubMed ID: 22743039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoid tumors of the rectum: a multi-institutional international collaboration.
    Shields CJ; Tiret E; Winter DC;
    Ann Surg; 2010 Nov; 252(5):750-5. PubMed ID: 21037430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of immunohistochemical lymphovascular evaluation to determine additional surgery after endoscopic submucosal dissection for colorectal T1 carcinoma.
    Nishimura T; Oka S; Tanaka S; Asayama N; Nagata S; Tamaru Y; Kuwai T; Yamashita K; Ninomiya Y; Kitadai Y; Arihiro K; Kuraoka K; Kaneko M; Shimamoto F; Chayama K
    Int J Colorectal Dis; 2021 May; 36(5):949-958. PubMed ID: 33150491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic potential in T1 and T2 colorectal cancer.
    Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC
    Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.